Statement of Principles concerning malignant neoplasm of the brain (Reasonable Hypothesis) (No. 17 of 2026)

Administered by Department of Veterans' Affairs

Legislation au F2026L00141 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

MALIGNANT NEOPLASM OF THE BRAIN

(REASONABLE HYPOTHESIS) (NO. 17 OF 2026)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1.              This is the Explanatory Statement to the Statement of Principles concerning malignant neoplasm of the brain (Reasonable Hypothesis) (No. 17 of 2026).

Background

  1.              The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), repeals Instrument No. 85 of 2016 (Federal Register of Legislation No. F2016L01692) determined under subsection 196B(2) of the VEA concerning malignant neoplasm of the brain.
  2.              The Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the brain and death from malignant neoplasm of the brain can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles concerning malignant neoplasm of the brain (Reasonable Hypothesis) (No. 17 of 2026).  This Instrument will in effect replace the repealed Statement of Principles.

Purpose and Operation

  1.              The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).
  2.              The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the brain or death from malignant neoplasm of the brain, with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

  1.              This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 30 October 2024 concerning malignant neoplasm of the brain in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.
  2.              The contents of this Instrument are in similar terms as the repealed Instrument.  Comparing this Instrument and the repealed Instrument, the differences include:
  • specifying a day of commencement for the Instrument in section 2;
  • revising the definition of 'malignant neoplasm of the brain' in subsection 7(2);
  • revising the reference to 'ICD-10-AM code' in subsection 7(4);
  • new factor in subsection 9(1) concerning traumatic brain injury;
  • new factor in subsection 9(2) concerning Parkinson’s disease;
  • new factor in subsection 9(4) concerning exposure to Benzene; and
  • deleting factor concerning being infected with human immunodeficiency virus.

Incorporation

  1.              The definition of "cumulative equivalent dose" contained in the Schedule 1 – Dictionary incorporates the Guide to calculation of 'cumulative equivalent dose' for the purpose of applying ionising radiation factors contained in Statements of Principles determined under Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian Radiation Protection and Nuclear Safety Agency, as in force on 2 August 2017.  This writing is incorporated pursuant to subsection 14(b) of the Legislation Act 2003.
  2.              A copy of this document is available to any person on the website of the Repatriation Medical Authority at www.rma.gov.au or from the Repatriation Medical Authority, Level 8, 480 Queen St, Brisbane, Queensland 4000, by contacting the Registrar on telephone (07) 3815 9404.

Consultation

  1.          Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to malignant neoplasm of the brain in the Government Notices Gazette of 30 October 2024, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority. 
  2.          On 17 October 2025, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instrument and the medical-scientific material considered by the Authority.  This letter emphasised the deletion of factors relating to HIV.  The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination.  No submissions were received for consideration by the Authority.  No changes were made to the proposed Instrument following this consultation process.

Human Rights

  1.          This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

 

Finalisation of Investigation

  1.          The determining of this Instrument finalises the investigation in relation to malignant neoplasm of the brain as advertised in the Government Notices Gazette of 30 October 2024.

References

  1.          A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 17 of 2026

Kind of Injury, Disease or Death: malignant neoplasm of the brain

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have malignant neoplasm of the brain;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting malignant neoplasm of the brain with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement;
  • replaces Instrument No. 85 of 2016; and
  • reflects developments in the available sound medical-scientific evidence concerning malignant neoplasm of the brain which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

 

 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning malignant neoplasm of the brain (Reasonable Hypothesis) (No. 17 of 2026) was enacted in 2026 to address the need for updated medical-scientific evidence regarding the connection between malignant neoplasm of the brain and certain kinds of military service. This legislative instrument was developed by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). The primary policy objective of this instrument is to facilitate the claims process for veterans and Defence Force members by specifying the circumstances under which medical treatment and compensation can be extended to those diagnosed with malignant neoplasm of the brain. This legislative instrument also ensures that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby promoting various human rights including the right to social security and the right to an adequate standard of living. The instrument serves to replace the previous Instrument No. 85 of 2016, reflecting advancements in medical-scientific evidence concerning malignant neoplasm of the brain. It specifies the factors that must exist to raise a reasonable hypothesis connecting malignant neoplasm of the brain with particular kinds of service, including operational, peacekeeping, hazardous, and warlike service. The Authority has determined this instrument in accordance with the available sound medical-scientific evidence and following a consultation process with relevant organisations and stakeholders.

Scope and Application

The Statement of Principles concerning malignant neoplasm of the brain (Reasonable Hypothesis) (No. 17 of 2026) applies to individuals who have served in specified categories of service under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). These categories include operational service, peacekeeping service, hazardous service, British nuclear test defence service under the VEA, and warlike and non-warlike service under the MRCA. The Statement of Principles outlines the minimum factors that must exist for a reasonable hypothesis to be raised, connecting malignant neoplasm of the brain or death from such a condition with the service circumstances. This document applies at the Commonwealth level, as it is determined under the VEA and the MRCA, and its provisions are enforced by the Repatriation Medical Authority. The Instrument does not specify any exclusions or exemptions but includes thresholds and conditions necessary to establish a reasonable hypothesis connecting the brain neoplasm with service. The Statement of Principles serves to replace the repealed Instrument No. 85 of 2016, reflecting updated medical-scientific evidence. The Authority has the power to extend or restrict the application of this Instrument through subordinate instruments, ensuring the provisions remain relevant and effective. The contents of this Instrument are incorporated under the Legislation Act 2003 and are available to the public through the Repatriation Medical Authority's website or by contacting the Authority directly.

Key Provisions

The Statement of Principles concerning malignant neoplasm of the brain (Reasonable Hypothesis) (No. 17 of 2026) sets out the factors that must exist to establish a reasonable hypothesis connecting malignant neoplasm of the brain, or death from such a neoplasm, to service rendered by a person under specific conditions. These conditions include operational, peacekeeping, hazardous, and British nuclear test defence service under the Veterans' Entitlements Act 1986 (VEA), as well as warlike and non-warlike service under the Military Rehabilitation and Compensation Act 2004 (MRCA). The factors include exposure to traumatic brain injury, Parkinson’s disease, and Benzene, while excluding infection with human immunodeficiency virus (HIV) as a factor. This Statement of Principles is intended to assist in determining claims and is based on the available sound medical-scientific evidence. The Repatriation Medical Authority (the Authority) is responsible for determining this Statement of Principles under subsection 196B(2) of the VEA. The Authority must consider the available sound medical-scientific evidence when determining these principles. The Authority must also ensure that the principles are compatible with human rights and freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. The Authority is required to advertise its intention to undertake an investigation in the Government Notices Gazette and invite submissions from relevant parties, including the Repatriation Commission, the Military Rehabilitation and Compensation Commission, and organisations representing veterans, service personnel, and their dependants. No changes were made to the proposed Instrument following the consultation process. Any breach of the obligations imposed by the Veterans' Entitlements Act 1986 or the Military Rehabilitation and Compensation Act 2004 may result in legal consequences, including civil or criminal penalties. The specific penalties depend on the nature and severity of the breach. Under the VEA, penalties may include fines, imprisonment, or both, while under the MRCA, penalties may include fines and imprisonment. The maximum penalties are not specified in the Explanatory Statement. In conclusion, the Statement of Principles concerning malignant neoplasm of the brain (Reasonable Hypothesis) (No. 17 of 2026) sets out the factors that must exist to establish a reasonable hypothesis connecting malignant neoplasm of the brain, or death from such a neoplasm, to service rendered by a person under specific conditions. The Repatriation Medical Authority is responsible for determining these principles, and any breach of the obligations imposed by the VEA or the MRCA may result in legal consequences, including civil or criminal penalties. The Statement of Principles is compatible with human rights and promotes the human rights of veterans, current and former Defence Force members, and other persons such as their dependents.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Human Rights Law
Consultation Requirements

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.